About this course

Hypertension remains to be a global health burden. Both the American College of Cardiology / American Heart Association (ACC/AHA) and European Society of Cardiology / European Society of Hypertension (ESC/ESH) recognizes the need for out-of-office blood pressure monitoring to identify both white coat hypertension or white coat syndrome, and masked hypertension. While there is no hard evidence to show long-term benefit of treatment of white coat hypertension with hypertension-mediated organ damage (HMOD) and masked hypertension due to methodological issues in studies, there is a recognized increased CV risk in both entities that may need to be addressed.

This e-learning module summarizes the diagnostic approach to masked and white coat hypertension, and reviews the data behind possible management options for these conditions.

Learning outcomes

• Diagnose and manage white coat hypertension and masked hypertension
• Identify the different hypertensive-mediated organ damage (HMOD) markers
• Understand the value of out-of-office BP monitoring and hopefully integrate it into clinical practice

Topics covered

• Introduction
• Diagnosing Hypertension
• Masked vs White Coat Hypertension
• To treat or not to treat: Management approach

Speaker for this course:

Michael John N. Barcelona, MD FPCP FPCC Internal Medicine – Adult and Interventional Cardiology